Formula ownership is the clause brands most often assume rather than check, and it is the one that decides whether they can ever change manufacturer. The question is not complicated, but the answer changes depending on how the product came to exist.
Almost every supplement project falls into one of three categories, and each carries a different default. Knowing which one you are in is the first step.
| Arrangement | How it arises | Typical ownership |
|---|---|---|
| Existing formula | Selected from the manufacturer's established range and sold under your brand — private label in the strict sense | The manufacturer owns the formula; the brand has the right to sell the finished product under its own label |
| Adapted formula | An existing base modified for you — an active level changed, an ingredient removed, a flavour or format adjusted | Ambiguous by default; the base and the adaptation may belong to different parties |
| Bespoke development | Commissioned and paid for by the brand, formulated around a specified brief | Normally transfers to the brand, and that transfer should be explicit |
The middle row is where most disputes sit. An adapted formula is common, commercially sensible and rarely documented precisely. If you are paying for development work but the base formula predates your project, the agreement needs to say which parts are yours.
Owning a formula on paper means little if you cannot act on it. Four practical rights should accompany it, and they are worth stating individually rather than assuming they travel with the word "ownership".
The right to have the product manufactured elsewhere, which requires enough technical detail to be reproducible — a formula name is not a transfer. The right to modify it in future. The right to know its composition in sufficient detail to answer a regulatory question or a customer query in your own market. And the right to prevent the same formulation being sold to a competitor.
That last point is exclusivity rather than ownership, and it is a separate commercial negotiation. A manufacturer can reasonably own a formula and still grant the brand exclusive use of it for a defined period, territory or market segment. Buyers who treat the two as the same thing tend to overpay for one and miss the other.
Exclusivity in this industry is usually granted with boundaries, and the boundaries are what you are negotiating. Four dimensions typically apply.
Exclusivity also has a legitimate commercial cost, because a manufacturer who reserves a successful formula for one buyer gives up other sales. It is normal for the price of exclusivity to be a volume commitment, and it is worth deciding deliberately whether you need it or whether simple ownership of a bespoke formula achieves the same thing more cheaply.
Whatever the arrangement, the test is whether it survives a manufacturer change. A handover pack that would pass that test contains the qualitative and quantitative formula, the manufacturing process parameters that affect the finished product, the specification and acceptance criteria, and the packaging specification. If a new manufacturer could take that pack and produce a comparable product, your position is real.
Two additional documents matter for a different reason. Records that let you trace a finished batch back to incoming materials support any future recall. And a signed confidentiality arrangement protects both parties during the negotiation itself, which is when formulations are most often shared informally.
Three questions, asked before a deposit rather than after, resolve most of this. Which of the three arrangements does our product fall into? If we wanted to move production in three years, what would need to be in this agreement for that to be possible? And is the exclusivity we are discussing priced separately, or included in the unit price?
The answers can change which formula you choose — because a slightly less convenient arrangement that you own outright may be worth more to you than a perfect match that you can never take anywhere else.
Usually the intention is that you do, but the transfer has to be explicit and complete enough to be reproducible elsewhere. Ask what the handover documents will contain.
No. Ownership concerns who the formula belongs to; exclusivity concerns who can use it. A manufacturer can grant one without the other, and they are priced differently.
Which arrangement applies, the practical rights that accompany ownership, the exclusivity boundaries, and the documentation you would receive on handover.
Clarifying formula ownership before you order? Shandong Guihe Pet Food Co., Ltd. manufactures pet supplements and pet food in Yishui County, Linyi, Shandong, with a 12,000 m² plant and 30,000 tons of annual capacity. See our OEM & ODM services, our OEM agreement checklist, or read how to choose a pet supplement contract manufacturer.